New inhaled treatment shows promise for rare lung condition
NCT ID NCT05343637
First seen Apr 25, 2026 · Last updated May 13, 2026 · Updated 2 times
Summary
This study tested an inhaled medication called RT234 in 14 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe. The goal was to see if the drug could lower lung blood pressure and improve blood flow. Participants received increasing doses during a heart catheterization procedure, and researchers monitored side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Hobart Hospital
Hobart, Tasmania, 7000, Australia
-
St Vincent's Hospital
Darlinghurst, New South Wales, 2010, Australia
-
The Alfred Hospital
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.